West-Ward Lobs $175M False Ad Suit At Generic-Drug Rivals

Law360, New York (March 15, 2013, 4:21 PM EDT) -- West-Ward Pharmaceutical Corp. hit generic-drug rivals Sandoz Inc. and American Regent Inc. with a $175 million false advertising suit in New Jersey federal court Thursday, accusing them of selling a blood pressure medication labeled with unsubstantiated and inaccurate information about uses, dosing and safety.

The complaint says Sandoz and American Regent lack "meaningful clinical evidence" their phenylephrine injections can address hypotension in patients who are anesthetized or experiencing septic shock, indications West-Ward claims it spent millions of dollars studying in order to win U.S. Food and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.